{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["MDR", "P-pg", "TCM components", "doxorubicin", "drug efflux pump", "reversal agent"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "28588693", "DateRevised": {"Year": "2020", "Month": "09", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "04", "Day": "03"}], "Language": ["eng"], "ELocationID": ["10.3892/ol.2017.5976"], "Journal": {"ISSN": "1792-1074", "JournalIssue": {"Volume": "13", "Issue": "6", "PubDate": {"Year": "2017", "Month": "Jun"}}, "Title": "Oncology letters", "ISOAbbreviation": "Oncol Lett"}, "ArticleTitle": "Effect of traditional Chinese medicine components on multidrug resistance in tumors mediated by P-glycoprotein.", "Pagination": {"StartPage": "3989", "EndPage": "3996", "MedlinePgn": "3989-3996"}, "Abstract": {"AbstractText": ["Multidrug resistance (MDR) is a major cause of chemotherapy failure. It occurs when an organism is resistant to one type of drug, but also develops resistance to other drugs with different structures and targets. There is a high incidence of MDR in cancer chemotherapy, therefore, finding an effective and non-toxic MDR reversal agent is an important goal, particularly for P-glycoprotein-mediated MDR in cancer. Improvements continue to be made to the status and understanding of traditional Chinese medicine (TCM), due to the advantages of low toxicity and relatively minor side effects. Therefore TCM is currently being used in the treatment of various types of diseases. In recent years, numerous components of TCM have been identified to be effective in reversing MDR by downregulating expression of the drug transporter membrane protein, recovering changes in enzymes involved in detoxification and metabolism and repairing the cell apoptosis pathway. The present study summarizes the anticancerous properties and MDR reversing components of traditional medicinal plants commonly used in the treatment of cancer."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Institute of Oncology, Jinan University, Guangzhou, Guangdong 510632, P.R. China."}], "LastName": "Xia", "ForeName": "Xi", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology and Molecular Medicine, Division of Cancer Biology and Genetics, Queen's University Cancer Research Institute, Kingston, ON K7L 3N6, Canada."}], "LastName": "Cole", "ForeName": "Susan P C", "Initials": "SPC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Science, Liaoning University, Shenyang, Liaoning 110036, P.R. China."}], "LastName": "Cai", "ForeName": "Tiange", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Institute of Oncology, Jinan University, Guangzhou, Guangdong 510632, P.R. China."}], "LastName": "Cai", "ForeName": "Yu", "Initials": "Y"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "Oncol Lett", "NlmUniqueID": "101531236", "ISSNLinking": "1792-1074"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Gottesman MM, Ling V. The molecular basis of multidrug resistance in cancer: The early years of P-glycoprotein research. FEBS Lett. 2006;580:998\u20131009. doi: 10.1016/j.febslet.2005.12.060.", "ArticleIdList": ["10.1016/j.febslet.2005.12.060", "16405967"]}, {"Citation": "Choi CH. ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell Int. 2005;5:30. doi: 10.1186/1475-2867-5-30.", "ArticleIdList": ["10.1186/1475-2867-5-30", "PMC1277830", "16202168"]}, {"Citation": "Leslie EM, Deeley RG, Cole SP. Multidrug resistance proteins: Role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol. 2005;204:216\u2013237. doi: 10.1016/j.taap.2004.10.012.", "ArticleIdList": ["10.1016/j.taap.2004.10.012", "15845415"]}, {"Citation": "Cole SP. Targeting multidrug resistance protein 1 (MRP1, ABCC1): Past, present, and future. Annu Rev Pharmacol Toxicol. 2014;54:95\u2013117. doi: 10.1146/annurev-pharmtox-011613-135959.", "ArticleIdList": ["10.1146/annurev-pharmtox-011613-135959", "24050699"]}, {"Citation": "Sharom FJ. ABC multidrug transporters: Structure, function and role in chemoresistance. Pharmacogenomics. 2008;9:105\u2013127. doi: 10.2217/14622416.9.1.105.", "ArticleIdList": ["10.2217/14622416.9.1.105", "18154452"]}, {"Citation": "Chikamori K, Grozav AG, Kozuki T, Grabowski D, Ganapathi R, Ganapathi MK. DNA topoisomerase II enzymes as molecular targets for cancer chemotherapy. Curr Cancer Drug Targets. 2010;10:758\u2013771. doi: 10.2174/156800910793605785.", "ArticleIdList": ["10.2174/156800910793605785", "20578986"]}, {"Citation": "Kartal-Yandim M, Adan-Gokbulut A, Baran Y. Molecular mechanisms of drug resistance and its reversal in cancer. Crit Rev Biotechnol. 2016;36:716\u2013726.", "ArticleIdList": ["25757878"]}, {"Citation": "Ren SX. The potential of Chinese herb on multidrug resistance. Pharmacy Clinics Chinese Materia Med. 2012;3:57\u201360."}, {"Citation": "Liao SL, Wang P. Research progress on multidrug resistance mechanism of cancer cells and its reversal agents. Guowai Yiyao Kangshengsu Fence. 2008;1:7\u201311. (In Chinese)"}, {"Citation": "Pan GD, Yan L. Advances in gene therapy of multidrug resistance reversal induced by Mdr1. Huaxi Yixue. 2007;22:205\u2013207. (In Chinese)"}, {"Citation": "Sharom FJ. The P-glycoprotein multidrug transporter. Essays Biochem. 2011;50:161\u2013178. doi: 10.1042/bse0500161.", "ArticleIdList": ["10.1042/bse0500161", "21967057"]}, {"Citation": "Cascorbi I. P-glycoprotein: Tissue distribution, substrates, and functional consequences of genetic variations. Handb Exp Pharmacol. 2011:261\u2013283. doi: 10.1007/978-3-642-14541-4_6.", "ArticleIdList": ["10.1007/978-3-642-14541-4_6", "21103972"]}, {"Citation": "Jones PM, George AM. Mechanism of the ABC transporter ATPase domains: Catalytic models and the biochemical and biophysical record. Crit Rev Biochem Mol Biol. 2013;48:39\u201350. doi: 10.3109/10409238.2012.735644.", "ArticleIdList": ["10.3109/10409238.2012.735644", "23131203"]}, {"Citation": "Ward AB, Szewczyk P, Grimard V, Lee CW, Martinez L, Doshi R, Caya A, Villaluz M, Pardon E, Cregger C, et al. Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain. Proc Natl Acad Sci USA. 2013;110:13386\u201313391. doi: 10.1073/pnas.1309275110.", "ArticleIdList": ["10.1073/pnas.1309275110", "PMC3746859", "23901103"]}, {"Citation": "Ueda K, Cornwell MM, Gottesman MM, Pastan I, Roninson IB, Ling V, Riordan JR. The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem Biophys Res Commun. 1986;141:956\u2013962. doi: 10.1016/S0006-291X(86)80136-X.", "ArticleIdList": ["10.1016/S0006-291X(86)80136-X", "2880583"]}, {"Citation": "Loo TW, Clarke DM. Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux. J Membr Biol. 2005;206:173\u2013185. doi: 10.1007/s00232-005-0792-1.", "ArticleIdList": ["10.1007/s00232-005-0792-1", "16456713"]}, {"Citation": "Crowley E, McDevitt CA, Callaghan R. Generating inhibitors of P-glycoprotein: Where to, now? Methods Mol Biol. 2010;596:405\u2013432. doi: 10.1007/978-1-60761-416-6_18.", "ArticleIdList": ["10.1007/978-1-60761-416-6_18", "PMC7121335", "19949934"]}, {"Citation": "Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced toxicity of vincristine and vinblastine by verapamil. Cancer Res. 1981;41:1967\u20131972.", "ArticleIdList": ["7214365"]}, {"Citation": "Tamaki A, Ierano C, Szakacs G, Robey RW, Bates SE. The controversial role of ABC transporters in clinical oncology. Essays Biochem. 2011;50:209\u2013232. doi: 10.1042/bse0500209.", "ArticleIdList": ["10.1042/bse0500209", "PMC6944313", "21967059"]}, {"Citation": "Huang SC, Xu J, Cai SH. Research progress of targeted reverse MDR mediated by P-glycoprotein. Huaxi Yaoxue Zazhi. 2009;24:551\u2013554. (In Chinese)"}, {"Citation": "Shen XL, Hu YJ, Yu ZL, Fong WF. Research progress on reversal of multidrug resistance of P-glycoprotein mediated by Chinese Herbs. Chinese J Natural Med. 2009;7:465\u2013475. doi: 10.3724/SP.J.1009.2009.00465.", "ArticleIdList": ["10.3724/SP.J.1009.2009.00465"]}, {"Citation": "Pusztai L, Wagner P, Ibrahim N, Rivera E, Theriault R, Booser D, Symmans FW, Wong F, Blumenschein G, Fleming DR, et al. Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy resistant, advanced breast carcinoma. Cancer. 2005;104:682\u2013691. doi: 10.1002/cncr.21227.", "ArticleIdList": ["10.1002/cncr.21227", "15986399"]}, {"Citation": "Li P, Chen S. Study of the ginsenoside Rh2 reversal MCF-7/ADM multidrug resistance. Guide Chin Med. 2013;11:8\u201310. (In Chinese)"}, {"Citation": "Piao L, Cai Y, Zhang M, Jiang J, Jin Z, Xu Z. Effects of gensenoside Rh2 combined with PI3K/AKT pathway inhibitor LY294002 on invasion and migration of breast cancer cells. China Pharmacy. 2013;24:4050\u20134052."}, {"Citation": "Xu X, Shi S, Tang Y, Shen H, Qian B. Therapeutic effects of ginsenoside Rh2 on multi-drug resistant leukemia cell line K562/VCR. Chin Trad Herbal Drugs. 2010;41:1131\u20131135. (In Chinese)"}, {"Citation": "Zhang B, Liu ZY, Li YY, Luo Y, Liu ML, Dong HY, Wang YX, Liu Y, Zhao PT, Jin FG, Li ZC. Antiinflammatory effects of matrine in LPS-induced acute lung injury in mice. Eur J Pharm Sci. 2011;44:573\u2013579. doi: 10.1016/j.ejps.2011.09.020.", "ArticleIdList": ["10.1016/j.ejps.2011.09.020", "22019524"]}, {"Citation": "Zhaowu Z, Xiaoli W, Yangde Z, Nianfeng L. Preparation of matrine ethosome, its percutaneous permeation in vitro and anti-inflammatory activity in vivo in rats. J Liposome Res. 2009;19:155\u2013162. doi: 10.1080/08982100902722381.", "ArticleIdList": ["10.1080/08982100902722381", "19241204"]}, {"Citation": "Yang Y, Xiu J, Zhang X, Zhang L, Yan K, Qin C, Liu J. Antiviral effect of matrine against human enterovirus 71. Molecules. 2012;17:10370\u201310376. doi: 10.3390/molecules170910370.", "ArticleIdList": ["10.3390/molecules170910370", "PMC6268984", "22932217"]}, {"Citation": "Li LQ, Li XL, Wang L, Du WJ, Guo R, Liang HH, Liu X, Liang DS, Lu YJ, Shan HL, Jiang HC. Matrine inhibits breast cancer growth via miR-21/PTEN/Akt pathway in MCF-7 cells. Cell Physiol Biochem. 2012;30:631\u2013641. doi: 10.1159/000341444.", "ArticleIdList": ["10.1159/000341444", "22832383"]}, {"Citation": "Jin H, Sun Y, Wang S, Cheng X. Matrine activates PTEN to induce growth inhibition and apoptosis in V600EBRAF harboring melanoma cells. Int J Mol Sci. 2013;14:16040\u201316057. doi: 10.3390/ijms140816040.", "ArticleIdList": ["10.3390/ijms140816040", "PMC3759898", "23912239"]}, {"Citation": "Zhang S, Zhang Y, Zhuang Y, Wang J, Ye J, Zhang S, Wu J, Yu K, Han Y. Matrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and Akt inactivation. PLoS One. 2012;7:e46853. doi: 10.1371/journal.pone.0046853.", "ArticleIdList": ["10.1371/journal.pone.0046853", "PMC3466205", "23056487"]}, {"Citation": "Yan F, Liu Y, Wang W. Matrine inhibited the growth of rat osteosarcoma UMR-108 cells by inducing apoptosis in a mitochondrial-caspase-dependent pathway. Tumour Biol. 2013;34:2135\u20132140. doi: 10.1007/s13277-013-0744-9.", "ArticleIdList": ["10.1007/s13277-013-0744-9", "23589054"]}, {"Citation": "Gui L, Li J, Chen B, Gao F, Wang J, Cai X. Effect of COX-2 inhibitor celecoxib, matrine and combination on multidrug resistance of K562/AO2 cell line. J Southeast Univ (Med Sci Edi) 2012;31:174\u2013178."}, {"Citation": "Wei C, Shen Y, Zhang Z, Wang J, Zhou B. Matrine reverses multidrug resistance in breast cancer drug-resistant cell line MCF-7/ADR through inhibiting PI3K/AKT signal pathway. J Third Mil Med Univ. 2014;36:2254\u20132258."}, {"Citation": "Zhan T. Matrine induces apoptosis of multidrug resistant CRBH-7919/mdr1 cells. Jilin Univ 1\u201384. 2012 (In Chinese)"}, {"Citation": "Wang J, Wang G, Liu M. Effects of quercetin on reversion of temozolomide resistance in U87/TR cell line. Yiyao Dao Bao. 2013;32:710\u2013714. (In Chinese)"}, {"Citation": "Wang H, Zhang H, Tao L, et al. Quercetin-induced strengthening efficiency to tamoxifen in tamoxifen-resistant breast cancer cells. Chin J Modern Med. 2014;24:39\u201344. (In Chinese)"}, {"Citation": "Wang Y, Liu Z, Zhang Q, Gao X, Zhang L, Liu H. Effect of quercetin on multidrug resistance reversal of lung adenocarcinoma cell line A549/DDP. J Binzhou Med Univ. 2013;26:86\u201389."}, {"Citation": "Wei Y, Zhang H, Liang G. The reverse effect of quercetin on multidrug resistance of human hepatocellular carcinoma. Tianjin Med J. 2013;40:1022\u20131025."}, {"Citation": "He HL, Ji LJ, Li QZ, Zhang R, Huang JM, Li G. Effect of quercetin on doxorubicin-induced expression of MDR1 gene in HL-60 cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015;23:70\u201376. (In Chinese)", "ArticleIdList": ["25687049"]}, {"Citation": "Ma J, Yang J, Shen H. The chemotherapy sensitivity analysis of the impact of reactive oxygen species on ovarian cancer cells COC1 and COC1/DDP. Biol Med Res Intl. 2014;30:535\u2013539. (In Chinese)"}, {"Citation": "Li J, Liu P, Mao H, Wanga A, Zhang X. Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro. Oncol Rep. 2009;21:1605\u20131610.", "ArticleIdList": ["19424643"]}, {"Citation": "Yu X, Wang S, Cao Y, Mo C, Li X, Li M. Effects of tetramethylpyrazine on P-glycoprotein in human drug resistant hepatocellular carcinoma cells BEL-7402/ADM. J Guangdong Pharmaceut Coll. 2010;26:635\u2013639. (In Chinese)"}, {"Citation": "Zhang Y, Liu X, Zuo T, Liu Y, Zhang JH. Tetramethylpyrazine reverses multidrug resistance in breast cancer cells through regulating the expression and function of P-glycoprotein. Med Oncol. 2012;29:534\u2013538. doi: 10.1007/s12032-011-9950-8.", "ArticleIdList": ["10.1007/s12032-011-9950-8", "21562851"]}, {"Citation": "Yang L, Zhao T, Bai Q, Dong H. Reversal effect and mechanism induced by baicalin on leukemia cell line. Shaxi Yixue Zazhi. 2012;7:775\u2013779. (In Chinese)"}, {"Citation": "Huang M, Jin J, Sun H, Liu GT. Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae. Cancer Chemother Pharmacol. 2008;62:1015\u20131026. doi: 10.1007/s00280-008-0691-0.", "ArticleIdList": ["10.1007/s00280-008-0691-0", "18270702"]}, {"Citation": "Wang M, Liu H, Yan M, Liu Z. Reversal effect of SchB on bladder tumor multidrug resistance. Natl Med Front Chin. 2010;5:28\u201329. (In Chinese)"}, {"Citation": "Li QP, Gai YN. Schisandrin B reverses multidrug resistance due to MDR1-mediatied human osteosarcoma cell line U-2 OS/ADR. Anhui Med Pharmaceut J. 2014;18:1642\u20131645."}, {"Citation": "Xu Q, Jin X, Guo R, Zhang X, Liu G. Schisandrin B reverses multidrug resistance of human colon cancer cells. Food Nutr Chin. 2011;17:64\u201366. (In Chinese)"}, {"Citation": "Qiangrong P, Wang T, Lu Q, Hu X. Schisandrin B-a novel inhibitor of P-glycoprotein. Biochem Biophys Res Commun. 2005;335:406\u2013411. doi: 10.1016/j.bbrc.2005.07.097.", "ArticleIdList": ["10.1016/j.bbrc.2005.07.097", "16084496"]}, {"Citation": "He JB, Liao HZ, Zhang YQ, et al. Reversal effect of ginsenoside Rg3 on multidrug resistance of lung adenocarcinoma in mice. J Practical Oncol. 2006;4:373\u2013377. (In Chinese)"}, {"Citation": "Li G, Wang M, Sun F, Wang X, Li X, Yin G. Reversal effect of multidrug resistance associated gene overexpression mediated induced by matrine on S180-tumor-bearing mice. J Chin Med Mater. 2006;29:40\u201342. (In Chinese)"}, {"Citation": "Han L, Wang Y, Guo X, Zhou Y, Zhang J, Wang N, Jiang J, Ma F, Wang Q. Downregulation of MDR1 gene by cepharanthine hydrochloride is related to the activation of c-Jun/JNK in K562/ADR cells. Biomed Res Int. 2014;2014:164391. doi: 10.1155/2014/164391.", "ArticleIdList": ["10.1155/2014/164391", "PMC4216687", "25386557"]}, {"Citation": "Han L. The multidrug resistance reversal effect of cepharanthine hydrochloride and its mechanism. Zhengzhou: Zhengzhou Univ 1\u2013119. 2013 (In Chinese)"}, {"Citation": "Lu W, Fu Z, Qin Y, Li L, Yang C. Curcumin reverses multidrug resistance in HCT-8/VCR nude mice xenograft. Di San Jun Yi Da Xue Xue Bao Bian Ji Bu. 2011;33:376\u2013380. (In Chinese)"}, {"Citation": "Xu DH. Overcome multidrug resistance by doxorubicin nanocarriers. Zhejiang Univ 1\u2013153. 2008 (In Chinese)"}, {"Citation": "Wang S, Yu S, Shi W, Ge L, Yu X, Fan J, Zhang J. Curcumin inhibits the migration and invasion of mouse hepatoma Hca-F cells through down-regulating caveolin-1 expression and epidermal growth factor receptor signaling. IUBMB Life. 2011;63:775\u2013782. doi: 10.1002/iub.507.", "ArticleIdList": ["10.1002/iub.507", "22362715"]}, {"Citation": "Liu TY, Tan ZJ, Jiang L, Gu JF, Wu XS, Cao Y, Li ML, Wu KJ, Liu YB. Curcumin induces apoptosis in gallbladder carcinoma cell line GBC-SD cells. Cancer Cell Int. 2013;13:64. doi: 10.1186/1475-2867-13-64.", "ArticleIdList": ["10.1186/1475-2867-13-64", "PMC3733655", "23802572"]}, {"Citation": "Xia Q, Wang ZY, Li HQ, Diao YT, Li XL, Cui J, Chen XL, Li H. Reversion of P-glycoprotein mediated multidrug resistance in human leukemic cell line by diallyl trisulfide. Evid Based Complement Alternat Med. 2012;2012:719805. doi: 10.1155/2012/719805.", "ArticleIdList": ["10.1155/2012/719805", "PMC3418761", "22919419"]}, {"Citation": "Zhao B. Molecular mechanisms of multi-drug resistance reversal via inhibition of P-glycoprotein function and expression by Grape seed procyanidin. Guangdong: Southern Medical Univ 1\u2013210. 2014 (In Chinese)"}, {"Citation": "Yuan F, Bai G, Miao YJ, Chen Y, Chen JW, Li X. Effects of annonaceous acetogenins against multidrug resistant human breast cancer cell line MCF-7/ADR in vitro. Chin Trad Herbal Drugs. 2014;45:2815\u20132819."}, {"Citation": "Sun YF, Wink M. Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandracan reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells. Phytomedicine. 2014;21:1110\u20131119. doi: 10.1016/j.phymed.2014.04.029.", "ArticleIdList": ["10.1016/j.phymed.2014.04.029", "24856768"]}, {"Citation": "Susa M, Choy E, Yang C, Schwab J, Mankin H, Hornicek F, Duan Z. Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay. J Biomol Screen. 2010;15:287\u2013296. doi: 10.1177/1087057109359422.", "ArticleIdList": ["10.1177/1087057109359422", "20150589"]}, {"Citation": "Wei N, Sun H, Wang F, Liu G. H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein. Cancer Chemother Pharmacol. 2011;67:1017\u20131025. doi: 10.1007/s00280-010-1397-7.", "ArticleIdList": ["10.1007/s00280-010-1397-7", "20640574"]}, {"Citation": "Cai Y, Cai T. Reversal effect of psoralen on leukemia cell K562/ADR multidrug resistance. Zhongguo Yaolixue Tongbao. 2003:1164\u20131166. (In Chinese)"}, {"Citation": "Qing Q, Xiao X, Xie Z. Effect of neferine combined with mdr-1shRNA on the expression of mdr-1/P-gp in K562/A02 cell line. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010;35:445\u2013450. (In Chinese)", "ArticleIdList": ["20543467"]}, {"Citation": "Huang C, Cao P, Xie Z, Zhu H. Effect of different heating methods combined with neferine on the expressions of \u03b3H2AX and mdr-1/P-gp in MCF-7/Adr breast cancer cells. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011;36:317\u2013322. (In Chinese)", "ArticleIdList": ["21566283"]}, {"Citation": "Li Z, An C, Hu K, Zhou K, Duan H, Tang M. Multidrug resistance reversal activity of total alkaloid from Fritillaria thunbergii on cisplatin-resistant human lung adenocarcinoma A549/DDP cells. Chin J Pharmacol Toxicol. 2013;27:315\u2013320."}, {"Citation": "Xu HB, Li L, Liu GQ. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Pharmazie. 2009;64:660\u2013665.", "ArticleIdList": ["19947169"]}, {"Citation": "Xu HB, Xu LZ, Li L, Fu J, Mao XP. Reversion of P-glycoprotein-mediated multidrug resistance by guggulsterone in multidrug-resistant human cancer cell lines. Eur J Pharmacol. 2012;694:39\u201344. doi: 10.1016/j.ejphar.2012.06.046.", "ArticleIdList": ["10.1016/j.ejphar.2012.06.046", "22960326"]}, {"Citation": "Yu H, Cui L, Pan Y. Reversal of drug resistance in multidrug-resistant MCF-7/ADR cells of breast cancer by artemisinin. Acta Med Univ Sci Technol Huazhong. 2011;40:91\u201394. (In Chinese)"}, {"Citation": "Liao K, Niu F, Hao H, Wang G. Advances on structure-activity relationship of NQO1-target antitumor quinones. Chin J Nat Med. 2012;10:170\u2013176. doi: 10.3724/SP.J.1009.2012.00170.", "ArticleIdList": ["10.3724/SP.J.1009.2012.00170"]}, {"Citation": "Liao SG, Wang Z, Li J, Liu Y, Li YT, Zhang LJ, Long QD, Wang YL. Cytotoxic sesquiterpene lactones from Vernonia bockiana. Chin J Nat Med. 2012;10:230\u2013233. doi: 10.3724/SP.J.1009.2012.00230.", "ArticleIdList": ["10.3724/SP.J.1009.2012.00230"]}]}], "History": [{"Year": "2016", "Month": "2", "Day": "14"}, {"Year": "2017", "Month": "2", "Day": "7"}, {"Year": "2017", "Month": "6", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "6", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "6", "Day": "8", "Hour": "6", "Minute": "1"}, {"Year": "2017", "Month": "4", "Day": "3"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28588693", "PMC5452909", "10.3892/ol.2017.5976", "OL-0-0-5976"]}}]}